Free Trial

Concentrix (CNXC) Competitors

Concentrix logo
$53.49 -0.47 (-0.87%)
Closing price 01/30/2025 04:00 PM Eastern
Extended Trading
$53.59 +0.10 (+0.19%)
As of 01/30/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CNXC vs. RTO, ALLE, CART, MEDP, ULS, WPP, FTAI, STN, HQY, and GLOB

Should you be buying Concentrix stock or one of its competitors? The main competitors of Concentrix include Rentokil Initial (RTO), Allegion (ALLE), Maplebear (CART), Medpace (MEDP), UL Solutions (ULS), WPP (WPP), FTAI Aviation (FTAI), Stantec (STN), HealthEquity (HQY), and Globant (GLOB). These companies are all part of the "business services" industry.

Concentrix vs.

Rentokil Initial (NYSE:RTO) and Concentrix (NASDAQ:CNXC) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.

Rentokil Initial has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, Concentrix has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500.

Rentokil Initial has higher earnings, but lower revenue than Concentrix.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rentokil Initial$6.68B1.89$473.93MN/AN/A
Concentrix$9.62B0.36$251.22M$3.7114.42

Concentrix received 21 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 55.56% of users gave Concentrix an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
Rentokil InitialOutperform Votes
4
30.77%
Underperform Votes
9
69.23%
ConcentrixOutperform Votes
25
55.56%
Underperform Votes
20
44.44%

9.9% of Rentokil Initial shares are held by institutional investors. Comparatively, 90.3% of Concentrix shares are held by institutional investors. 3.1% of Concentrix shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Concentrix has a consensus price target of $75.00, suggesting a potential upside of 40.21%. Given Concentrix's stronger consensus rating and higher probable upside, analysts plainly believe Concentrix is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rentokil Initial
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71
Concentrix
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.00

Rentokil Initial pays an annual dividend of $0.36 per share and has a dividend yield of 1.4%. Concentrix pays an annual dividend of $1.33 per share and has a dividend yield of 2.5%. Concentrix pays out 35.8% of its earnings in the form of a dividend.

Concentrix has a net margin of 2.61% compared to Rentokil Initial's net margin of 0.00%. Concentrix's return on equity of 16.67% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
Rentokil InitialN/A N/A N/A
Concentrix 2.61%16.67%5.63%

In the previous week, Rentokil Initial had 9 more articles in the media than Concentrix. MarketBeat recorded 14 mentions for Rentokil Initial and 5 mentions for Concentrix. Concentrix's average media sentiment score of 1.06 beat Rentokil Initial's score of 0.06 indicating that Concentrix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rentokil Initial
2 Very Positive mention(s)
2 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Concentrix
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Concentrix beats Rentokil Initial on 13 of the 19 factors compared between the two stocks.

Get Concentrix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNXC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNXC vs. The Competition

MetricConcentrixBusiness services IndustryBusiness SectorNASDAQ Exchange
Market Cap$3.47B$21.68B$8.00B$9.14B
Dividend Yield2.65%2.62%2.21%3.98%
P/E Ratio14.4229.0928.8917.66
Price / Sales0.369.83101.6881.09
Price / Cash3.4334.3231.2537.71
Price / Book0.866.056.134.73
Net Income$251.22M$522.19M$137.16M$225.42M
7 Day Performance2.00%2.11%-1.31%-0.44%
1 Month Performance24.57%5.19%-1.20%3.57%
1 Year Performance-40.43%12.48%20.64%19.20%

Concentrix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNXC
Concentrix
4.8822 of 5 stars
$53.49
-0.9%
$75.00
+40.2%
-40.4%$3.47B$9.62B14.42440,000Short Interest ↑
Positive News
RTO
Rentokil Initial
0.6235 of 5 stars
$24.52
+1.4%
N/A-5.5%$12.38B$6.68B0.0062,900
ALLE
Allegion
3.9399 of 5 stars
$134.91
+1.8%
$140.83
+4.4%
+5.8%$11.73B$3.65B20.7212,400Short Interest ↑
CART
Maplebear
3.4339 of 5 stars
$45.38
-1.3%
$48.96
+7.9%
+92.1%$11.65B$3.04B30.453,380Short Interest ↓
MEDP
Medpace
4.3096 of 5 stars
$347.36
+1.0%
$381.44
+9.8%
+15.9%$10.80B$1.89B30.425,900Short Interest ↓
ULS
UL Solutions
1.7326 of 5 stars
$52.43
-1.6%
$49.00
-6.5%
N/A$10.49B$2.68B0.0015,233Short Interest ↓
WPP
WPP
1.4216 of 5 stars
$46.38
+1.0%
N/A-4.5%$10.01B$18.46B0.00114,732
FTAI
FTAI Aviation
4.3319 of 5 stars
$90.37
-0.7%
$171.75
+90.1%
+90.9%$9.27B$1.17B-903.5940
STN
Stantec
2.4771 of 5 stars
$79.01
-2.8%
N/A-3.3%$9.01B$4.80B35.9128,000Positive News
HQY
HealthEquity
2.9967 of 5 stars
$104.07
-2.6%
$110.71
+6.4%
+43.2%$9.01B$999.59M95.393,150Positive News
GLOB
Globant
4.8576 of 5 stars
$205.82
+0.9%
$231.28
+12.4%
-15.7%$8.87B$2.10B53.7429,150Short Interest ↑
Analyst Revision

Related Companies and Tools


This page (NASDAQ:CNXC) was last updated on 1/31/2025 by MarketBeat.com Staff
From Our Partners